05.17.19

Neuropathy May Drive Dry Eye in Migraine Patients

Source: Reuters

05.14.19

Allegro Announces Positive Results of Ex-US Proof-of-Concept Trial With ALG-1007 for Dry Eye Disease

Source: Allegro Ophthalmics

05.13.19

ReGenTree Initiates ARISE-3 (Phase 3) Trial for Dry Eye Syndrome

Source: ReGenTree

05.08.19

Novartis to Acquire Dry Eye Drug Xiidra in Deal Worth Up to $5.3 Billion

Source: Eyewire News

04.30.19

Allegro to Present Results of Its ALG-1007 Ex-US Trial for Dry Eye Disease at ASCRS

Source: Allegro Ophthalmics

04.25.19

Allegro Expands Its Anti-Integrin Portfolio with New Dry Eye Disease Drug Candidate ALG-1007

Source: Allegro Ophthalmics

04.16.19

SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA for Dry Eye Drop

Source: SilkTech Biopharmaceuticals

03.26.19

RegeneRx and Lee’s Pharm to Accelerate RGN-259 Development in China

Source: RegeneRx

03.21.19

Study Examines Using Re-Esterified Omega-3 and Maqui Berry in Combination as a Treatment for Dry Eye Disease

Source: Focus Laboratories

02.28.19

Aldeyra Therapeutics Provides Update on Ophthalmic Programs

Source: Aldeyra Therapeutics

View more stories